Trademark Information
Listed below are product trademarks, and their owners, that appear on the Bristol-Myers Squibb website. Bristol-Myers Squibb trademarks include those of its divisions and subsidiary companies.
ABILIFY® (aripiprazole) – Otsuka Pharmaceutical Co., Ltd.
ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) – Bristol-Myers Squibb and Gilead Sciences, LLC
AVALIDE® (irbesartan hydrochlorothiazide) – Sanofi-Aventis
AVAPRO® (irbesartan) – Sanofi-Aventis
AZACTAM® (aztreonam) – Bristol-Myers Squibb
BARACLUDE® (entecavir) – Bristol-Myers Squibb
BICNU® (carmustine) – Bristol-Myers Squibb
BLENOXANE® (bleomycin sulfate) – Bristol-Myers Squibb
BUSPAR® (buspirone hydrochloride) – Bristol-Myers Squibb
CAPOTEN® (captopril) – Par Pharmaceutical, Inc.
CARDIOLITE® (Kit for the preparation of technetium tc99m sestamibi) – Lantheus Medical Imaging, Inc.
CEENU® (lomustine) – Bristol-Myers Squibb
CEFZIL® (cefprozil) – Bristol-Myers Squibb
COUMADIN® (warfarin sodium) – Bristol-Myers Squibb
DROXIA® (hydroxyurea) – Bristol-Myers Squibb
ERBITUX® (cetuximab) – ImClone LLC
ETOPOPHOS® (etoposide phosphate) – Bristol-Myers Squibb
EXCEDRIN® Migraine – Novartis AG
GLUCOPHAGE® (metformin hydrochloride) – Merck Sante Corporation
GLUCOPHAGE® XR EXTENDED RELEASE (metformin hydrochloride) – Merck Sante Corporation
GLUCOVANCE® (glyburide and metformin hydrochloride) – Merck Sante Corporation
HYDREA® (hydroxyurea) – Bristol-Myers Squibb
Ipana® – Maxill, Inc.
IXEMPRA® (ixabepilone) – Bristol-Myers Squibb
KENALOG®-10 (triamcinolone acetonide) – Bristol-Myers Squibb
KENALOG®-40 (triamcinolone acetonide) – Bristol-Myers Squibb
KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release) – Bristol-Myers Squibb
LYSODREN® (mitotane) – Bristol-Myers Squibb
MEGACE® (megestrol acetate) – Bristol-Myers Squibb
METAGLIP® (glipizide and metformin hydrochloride) – Merck Sante Corporation
MONOPRIL® (fosinopril sodium) – Bristol-Myers Squibb
MUTAMYCIN® (mitomycin) – Bristol-Myers Squibb
NULOJIX® (belatacept) - Bristol-Myers Squibb
NYDRAZID® (isoniazid) – Bristol-Myers Squibb
ONGLYZA® (saxagliptin) – Bristol-Myers Squibb
ORENCIA® (abatacept) – Bristol-Myers Squibb
PARAPLATIN® (carboplatin) – Bristol-Myers Squibb
PLAVIX® (clopidogrel bisulfate) – Sanofi-Aventis
PRAVACHOL® (pravastatin sodium) – Bristol-Myers Squibb
RECOTHROM® Thrombin, topical (recombinant) – Bristol-Myers Squibb
REYATAZ® (atazanavir sulfate) – Bristol-Myers Squibb
SINEMET® (carbidopa-levodopa) – Merck Sharpe & Dohme Corp.
SINEMET® CR (carbidopa-levodopa) – Merck Sharpe & Dohme Corp.
SPRYCEL® (dasatinib) – Bristol-Myers Squibb
SUSTIVA® (efavirenz) – Bristol-Myers Squibb
TAXOL® (paclitaxel) – Bristol-Myers Squibb
TEQUIN® (gatifloxacin) – Bristol-Myers Squibb
TESLAC® (testolactone) – Bristol-Myers Squibb
VEPESID® (etoposide) – Bristol-Myers Squibb
VIDEX® (didanosine) – Bristol-Myers Squibb
VIDEX® EC DELAYED RELEASE (didanosine) – Bristol-Myers Squibb
VUMON® (teniposide) – Bristol-Myers Squibb
YERVOY™ (ipilimumab) – Bristol-Myers Squibb
ZERIT® (stavudine) – Bristol-Myers Squibb
Please click on the product links to see the Full Prescribing Information including Boxed WARNINGS for ABILIFY®, ATRIPLA®, BARACLUDE®, COUMADIN®, and NULOJIX®, Boxed WARNING for YERVOY™ regarding immune-mediated adverse reactions, Boxed WARNINGS for ERBITUX® regarding infusion reactions and cardiopulmonary arrest, and Boxed WARNINGS for AVAPRO® and AVALIDE® regarding use in pregnancy. As soon as pregnancy is detected, discontinue use of AVAPRO® or AVALIDE®.